Biohaven Therapeutics Ltd.

This study aims to see if the drug troriluzole can slow the progression of spinocerebellar ataxia (SCA), a rare genetic disorder that affects movement and coordination, over three years. It compares data from about 909 people who took the drug in a previous long-term study to dat…

This study is checking the long-term safety of an experimental drug called BHV-7000 for adults with focal epilepsy that doesn't respond well to current treatments. It's enrolling 660 people worldwide who have already been in a related earlier study. The main goal is to see if peo…

This early-stage study is testing whether an investigational drug called BHV-7000 can reduce chronic pain in adults with inherited erythromelalgia, a rare genetic disorder that causes severe burning pain. The study will compare the drug to a placebo in a small group of 5 particip…